To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Middle East

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions

Growth Disorders

Interventions

DEVICE

easypod™

Saizen® (Somatropin) as per Summary of Product Characteristics administered by easypod™

Trial Locations (1)

For Recruiting Locations in the United Arab Emirates and the Kingdom of Saudi Arabia, Please Contact the Merck KGaA Communication Center

All Listed Sponsors

collaborator

Merck Serono Middle East FZ LLC

INDUSTRY

lead

Merck KGaA, Darmstadt, Germany

INDUSTRY

NCT02015286 - To Assess the Level of Adherence of Subjects Receiving SAIZEN® Via Easypod™ in Middle East | Biotech Hunter | Biotech Hunter